Ayahuasca, Esketamine and PTSD
ConditionPosttraumatic Stress Disorder (PTSD)
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18-65
SponsorUniversity of Sao Paulo
About this trial
Double-blind, randomized trial comparing a single dose of oral ayahuasca or esketamine in patients with posttraumatic stress disorder.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
posttraumatic stress disorder
Disqualifiers
psychiatric and other medical comorbidities
Trial design
Design model
Parallel
Treatments tested in this trial
Ayahuasca
Drugoral ayahuasca
Esketamine
Drugoral esketamine
Treatment groups
10 Participants
are divided into 2 treatment groupsGroup A: AyahuascaExperimental treatment 1 intervention
Group B: esketamineActive comparator 1 intervention
Trial outcomes
Primary outcomes
1
Posttraumatic Stress Disorder Checklist for DSM-5
higher scores mean a worse outcome
Time frame
From enrollment to the end of treatment at 3 weeksSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov